Oracle delivered a fundamentally spectacular quarter and the market sold it anyway, and that disconnect is now the entire story. Fiscal Q1 FY27 revenue grew 30% to $19.3B (vs. $19.13B expected), adjusted of $1.92 beat the $1.75 bar by 10.4%, OCI exploded 121% to $7.4B, more than $30B of new AI cloud contracts pushed RPO to $664B, and management guided Q2 revenue up 30-34% with cloud up 65-71% — yet on September 11 the stock gapped up 7.5% to open at $164.43, traded to $165.99, and reversed to close at $150.28, down 1.8%, on 78.5M shares (2.95x the 20-day average) with deteriorating to -851.6M, the distribution signature of institutions using the beat as an exit. The sell-side reactions explain why: BMO cut its target $220-to-$195 citing a sequential gross-margin decline and disappointing 10% SaaS growth, RBC cut $190-to-$165 to Sector Perform, and Stifel cut $220-to-$200, while UBS was the outlier, raising $245-to-$250 — a post-print debate shift from 'can Oracle grow?' to 'what are the margins and funding costs of that growth?'. The macro regime hardened against the name exactly on cue: hot CPI data pushed rate-hike odds to ~90% for next Wednesday's Fed meeting with the 10-year at 4.97%, punitive for a beta-1.73 name carrying $135.5B of net debt, -5.67% FCF yield, and a ~$40B FY27 debt raise still ahead. A second shadow risk emerged: OpenAI — Oracle's marquee counterparty — is reportedly considering pacing its frontier-model development, which if coordinated industry-wide would directly threaten the AI-compute demand assumptions underpinning the $664B backlog. Technically, the medium-term structure is intact but cracking at the edges: price barely holds the ($149.38) and ($149.89), the histogram has collapsed from +1.607 to +0.462 over three sessions with a bearish /signal crossover imminent, and price remains 14.9% below the at $176.70 with the death cross intact. The offsetting positives are real — fell to 15.84, revisions show zero downward moves across all horizons with the +1y estimate rising from $10.87 to $11.02, 36 of 44 analysts at Buy or better, and a mean $241.41 target implying ~61% upside from $150.28 on a 0.86x . We cut the score to 54 (HOLD) from 70: the 1-year thesis remains BUY on contracted growth at 13.67x forward earnings, but the 1-month and 6-month views are HOLD given the gap-and-fail distribution, margin compression, and a rate-hike event days away — the discipline now is to let the $142-$146 shelf prove it holds before adding.
投资判断
实时价格
$150.28
推荐分数
54%
54%
置信度
62%
62%
各期限展望
1个月
持有
短线
6个月
持有
中期
1年
买入
长期
核心催化
The combination of the earnings gap-and-fail and the BMO margin critique is the market-moving pivot: a 10.4% beat and 121% OCI growth produced a 7.5% gap that was sold down to a 1.8% loss on 78.5M shares (2.95x volume), with BMO's cut to $195 articulating why — sequential gross-margin decline, 10% SaaS growth, and negative quarterly FCF of ~$5B. The market has moved the debate from demand to economics, and the next catalysts (Fed hike, debt-raise pricing, October analyst meeting) all bear on funding costs, not growth.
Despite calming to 15.84, size at 50% of normal or less: the gap-and-fail distribution on 2.95x volume, a ~90%-priced Fed hike next Wednesday, the margin-compression debate, and an of $7.77 (~5.2% of price) all argue for patience. Do not chase strength above $159; accumulate only if the $142-$146 shelf holds on declining volume after the Fed decision, and add toward normal size only on a reclaim of $159.70 that repairs the momentum picture.
投资逻辑快照
什么情况涨
The fundamental case actually strengthened this week even as the stock fell: Oracle booked more than $30B of new AI cloud contracts in a single quarter, grew OCI 121% to $7.4B, beat by 10.4%, guided Q2 revenue up 30-34% and cloud up 65-71%, generated a record ~$23B of operating cash flow, and management stated demand 'continues to grow faster than supply' — all while the +1y estimate rose from $10.87 to $11.02 with zero downward revisions in 30 days. At $150.28 the stock offers 13.67x forward earnings and a 0.86x on growth most software companies cannot approach, with $664B of contracted RPO (roughly 9x annual revenue) providing multi-year visibility, a mean analyst target of $241.41 implying ~61% upside, 36 of 44 firms at Buy or better, and UBS actually raising its target to $250 post-print. The technical damage is a positioning event, not a thesis event — the higher-low sequence from $114.50 still holds, and the prior analysis' $172-$190 exit band remains the realistic objective once the margin debate and Fed hike pass. The score history (58→62→70→52→56→64→70→now 54) shows this is a volatile thesis that has consistently rewarded patience at structural support.
什么情况跌
The market answered the earnings beat with the clearest distribution signature possible: a 7.5% gap sold down to a 1.8% loss on 78.5M shares (2.95x average volume), with at -851.6M near window lows — institutions with the best information exited into the strongest demand print Oracle has ever delivered, which suggests sophisticated money believes the margin and funding problems are worse than the guidance admits. BMO's critique is specific and quantitative: sequential gross-margin decline, SaaS growth of only 10%, and quarterly FCF of roughly negative $5B even at record operating cash flow. RBC downgraded to Sector Perform and cut $190-to-$165; the $110 low street target still implies 27% downside. The macro turn is the amplifier: ~90% odds of a Fed hike next week at a 4.97% 10-year against $167.4B of debt and a ~$40B raise that must now price into a tightening cycle. And the concentration risk finally surfaced — OpenAI publicly weighing a slowdown in frontier-model development puts the quality of the very counterparties behind the $664B RPO in question. If the debt raise prices at punitive spreads, or if OpenAI's pacing becomes coordinated, this equity can retrace to the July base regardless of 30% revenue growth.
A daily close below $138 (breaking the $139.95 September 1 swing low) on above-average volume invalidates the post-earnings structure and mandates exit. Fundamentally, the thesis breaks on any of: the ~$40B FY27 debt raise pricing at spreads implying credit stress, an OpenAI or other major counterparty formally reducing committed AI cloud spend (impairing RPO conversion), or Q2 cloud/OCI growth decelerating materially below the guided 30-34%/65-71% trajectory.
Fed rate-hike probability of ~90% for next Wednesday with the 10-year at 4.97% directly raises the cost of Oracle's $167.4B debt stack and the pending ~$40B FY27 raise — with beta of 1.73, 47.5% realized volatility, and ~4.2x net leverage, a 20-30% equity decline is possible irrespective of operating performance.
The $664B RPO is concentrated in a small set of AI counterparties, and OpenAI — the marquee name — is now publicly weighing a slowdown in frontier-model development; a single counterparty demand pause would simultaneously impair backlog conversion, the 121% OCI growth rate, and the margin-improvement path.
Gross margin declined sequentially per BMO while SaaS grew only 10% to $4.2B — the growth mix is rotating toward lower-margin, capital-intensive infrastructure delivery, threatening the 65.8% gross margin and 45.3% margin that justify premium valuation, with quarterly FCF running at roughly -$5B even at record operating cash flow.
Technically, the gap-and-fail on 2.95x volume with at -851.6M and the histogram collapsing from +1.607 to +0.462 means the primary downtrend (price 14.9% below the at $176.70, death cross intact) is being actively confirmed rather than repaired — a close below $149.38 opens $142.35 and $139.95 rapidly.
接下来关注
下一次财报：2026年12月10日
The combination of the earnings gap-and-fail and the BMO margin critique is the market-moving pivot: a 10.4% beat and 121% OCI growth produced a 7.5% gap that was sold down to a 1.8% loss on 78.5M shares (2.95x volume), with BMO's cut to $195 articulating why — sequential gross-margin decline, 10% SaaS growth, and negative quarterly FCF of ~$5B. The market has moved the debate from demand to economics, and the next catalysts (Fed hike, debt-raise pricing, October analyst meeting) all bear on funding costs, not growth.
信号仪表盘
决策输入
6 个信号
基本面
60.6%
距分析师均值目标空间
At $150.28, ORCL trades at 23.55x trailing , 13.67x forward , 0.86x , 6.43x , and 19.07x on a $432.9B market cap — optically cheap against revenue growth of 20.6% accelerating to a guided 30-34% next quarter, and the mean $241.41 target implies ~61% upside. But the capital-structure adjustment is the honest lens: enterprise value of $581.6B sits 1.34x above market cap on $135.5B of net debt (-31.3% of market cap), the -5.67% FCF yield prices explicit funding risk, and 19.07x is not cheap for a business whose gross margins just declined sequentially per BMO's post-print note. The earnings print strengthened the numerator (RPO $664B, OCI +121%, $30B of new contracts) but the denominator story — margins and cash conversion — is now under active debate, with BMO explicitly flagging the tension of converting backlog without margin deterioration. At 4.97% on the 10-year with the Fed poised to hike, the market will not award full multiples to this balance sheet until the FY27 debt raise prices acceptably and FCF inflects. Net: cheap relative to growth, fairly valued relative to its leverage, with the discount justified until cash generation turns.
技术面
Bearish
趋势质量
The September 11 session was a textbook gap-and-fail: the stock opened at $164.43 (+7.5% from the $152.94 prior close on the earnings beat), traded to $165.99, and reversed to close at $150.28 — a $15.72 intraday giveback (~10.7% of price) that fully filled the earnings gap and closed below the pre-earnings close. Price now sits in a knife's-edge position: marginally above the at $149.38 and the at $149.89, but 14.9% below the at $176.70 with the / death cross intact and unrepaired. The higher-low sequence from the $114.50 July bottom still technically holds ($139.95 Sep 1 low > $114.50), but the failed breakout above the $159.70-$163 supply zone — the second rejection of that zone in a week — leaves resistance layered at $159.70-$163 (gap/supply), $170.70 (Sep 8 reversal high), and the at $176.70. Support steps down through $149.38-$149.89 (/, now being tested), $146.69 (Sep 2 high/breakout structure), $142.35 (Aug 18 low), and $139.95 (Sep 1 low) as the last shelf before the July base.
财报
89天
Accelerating
Q1 FY27 delivered revenue of $19.3B (+30% YoY, vs. $19.13B expected), adjusted of $1.92 vs. $1.75 expected (+10.4% beat), OCI up 121% to $7.4B, more than $30B of new AI cloud contracts lifting RPO to $664B, record ~$23B operating cash flow — yet the stock gapped up 7.5% and reversed to close down 1.8% on 2.95x volume as BMO flagged sequential gross-margin decline and 10% SaaS growth.
新闻
Mixed-Bullish
新闻基调
The combination of the earnings gap-and-fail and the BMO margin critique is the market-moving pivot: a 10.4% beat and 121% OCI growth produced a 7.5% gap that was sold down to a 1.8% loss on 78.5M shares (2.95x volume), with BMO's cut to $195 articulating why — sequential gross-margin decline, 10% SaaS growth, and negative quarterly FCF of ~$5B. The market has moved the debate from demand to economics, and the next catalysts (Fed hike, debt-raise pricing, October analyst meeting) all bear on funding costs, not growth.
宏观
Neutral
4.97% 10Y / 15.8 VIX
falling to 15.84 restores calm, but the regime's defining feature for Oracle is monetary: hot CPI has rate-hike odds at ~90% for next week with the 10-year at 4.97% — a rate-hiking cycle is maximally punitive for a beta-1.73, 388.9%-levered, negative-FCF growth name that must refinance ~$40B of debt.
稳定性
High-Beta Growth
Satellite Upside
Oracle owns one of the most impressive demand franchises in large-cap tech — Q1 FY27 revenue up 30% to $19.3B, OCI up 121% to $7.4B, $30B of new AI contracts booked in a single quarter, and $664B of RPO — but the equity remains a leveraged, cash-flow-negative expression of that franchise: $167.4B of total debt, 388.9% , -$24.5B FCF, a -5.67% FCF yield, and a pending ~$40B fiscal-2027 debt raise now facing a Federal Reserve that markets price at ~90% odds of a rate hike next week with the 10-year at 4.97%. The earnings-day tape proved the point: the stock gapped up 7.5% to $164.43, traded as high as $165.99, and closed at $150.28 on 78.5M shares (2.95x the 20-day average) — institutional distribution into validated good news. With beta of 1.73, 47.5% realized volatility, a 54.4% drawdown from the $329.50 high, and now a margin-compression debate (BMO flagged sequential gross-margin decline and 10% SaaS growth), 20-30% air pockets remain fully possible. This is a satellite position for investors who can underwrite double-digit drawdowns, not a core anchor.
分析师目标区间
均值目标
$241.41
高低目标
$110 / $400
分析师中值目标
$240.00
共识区间
$110 - $400
— 位分析师
Mean
$110$241$400
市场共识
The mean target of $241.41 (median $240) implies ~61% upside from $150.28, but the $110-$400 range is extreme dispersion, and the fresh post-print actions reveal the active debate: RBC at $165, BMO at $195, Stifel at $200, DA Davidson at $225, TD Cowen at $240, UBS at $250 — the fresh-action consensus band of roughly $165-$250 brackets the current price tightly at the low end, meaning sell-side models built on 30%+ growth still imply 10-66% upside while flagging margin risk. With 36 of 44 firms at Buy or better, zero rating changes in 90 days, and the 10.4% beat against the guided 30-34% Q2 growth, the fundamental consensus remains firmly constructive — the market's 54.4% discount to the 52-week high is a statement about balance sheet and margin risk, not demand, and that gap closes only when FCF turns or the debt raise prices well.
筹码脉冲
内部人信号
Moderate Sell
净偏向
Sell-heavy
内部人持股
40.5%
机构持股
45.8%
解读
Insider activity remains a mild caution flag post-print: sell-only filings and zero discretionary buying through a drawdown that offered compelling accumulation prices signal limited insider conviction in the near-term equity, though the dollar amounts are immaterial to a $433B market cap and the ATM was a disclosed structured funding program rather than a discretionary view.
重要活动
Officer Edward Lloyd Screven filed two direct-disposition transactions totaling 74,442 shares for roughly $6.7M combined ($5.22M and $1.51M). No open-market insider purchases appear anywhere in the available window — no insider bought through the 54.4% drawdown from the $329.50 high or the $114.50 July low, and the completed $20B ATM made the company itself a net seller of equity into weakness.
市场背景
行业
Software - Infrastructure
Neutral
情绪
10
跟踪股票
10
分组
industry
Software - Infrastructure 行业 当前情绪为 Neutral，板块平均评分约 56 分，整体偏稳，且leadership is concentrated in MSFT, PLTR, PANW。
Oracle's print remains a demand-side confirmation for the AI infrastructure theme — 121% OCI growth, $30B of new contracts, and $664B of RPO — and the theme's second-tier names rallied on the read-through (CoreWeave +2.5%, Nebius +2.4%, IREN +1.4%, with Dell +12% and HPE +12% to records). But the theme's internal rotation is now differentiating: capital is rewarding the builders whose returns on capital are demonstrable (server/hardware chains, GPU-native clouds with lighter leverage) while punishing the most leveraged builder whose incremental growth arrives with shrinking gross margins and negative free cash flow. The theme is intact but its risk premium has migrated from demand to unit economics and financing.
Oracle's September 10-11 print-and-fade delivered simultaneously the strongest demand datapoint in months and the sharpest margin warning, forcing the theme to reprice its weakest-balance-sheet expression while lifting its hardware and GPU-cloud beneficiaries.
Dell +12% to a record and HPE +12% on Oracle's beat shows capital rotating toward the capex-receiving layer of AI infrastructure where revenue converts to cash immediately, away from the debt-funded builder layer where conversion is backlogged and margin-dilutive.
BMO's target cut on Oracle for sequential gross-margin decline establishes a new template: sell-side is now grading AI builders on margin trajectory and FCF, not bookings — a rotation criterion shift that favors self-funded hyperscalers and GPU-native clouds over leveraged neoclouds.
OpenAI reportedly considering pacing frontier-model development is the theme's first credible demand-side crack — if coordinated, it would compress the multi-year visibility that justifies capacity pre-builds across the entire cohort.
AI Credit & Concentration Risk
评分: -45
Bearish
The credit-and-concentration critique of Oracle reasserted itself forcefully this week and is now the dominant near-term narrative: the completed $20B ATM no longer offsets a deteriorating macro for leveraged credit, with hot CPI driving ~90% rate-hike odds for next Wednesday and the 10-year at 4.97% against $167.4B of debt, -$24.5B trailing FCF, and a ~$40B FY27 raise still pending. Simultaneously, the counterparty leg of the risk materialized — OpenAI, Oracle's most important AI customer, is reportedly weighing a slowdown in frontier-model development, putting the quality of the $664B RPO in play. BMO's gross-margin cut and RBC's $190-to-$165 downgrade to Sector Perform show the sell-side is actively marking down the equity's claim on the backlog.
Three credit-relevant shocks landed within 48 hours: the earnings-day distribution on 2.95x volume, a 90%-priced Fed hike against the pending $40B debt raise, and OpenAI signaling possible demand pacing — each independently raises the discount rate on Oracle's backlogged cash flows.
The Fed hiking cycle at ~90% odds next week directly reprices the cost of Oracle's $167.4B debt stack and the ~$40B FY27 raise — leveraged growth names are structurally disadvantaged in this regime versus cash-generative hyperscalers.
OpenAI's potential frontier-model pacing, per Bloomberg via Yahoo coverage, introduces counterparty-quality risk into the $664B RPO — the first public signal that Oracle's largest AI counterparties might slow the compute consumption that justifies pre-building capacity.
RBC's downgrade to Sector Perform with a $190-to-$165 cut, following BMO's $220-to-$195 cut, shows the sell-side is now underwriting the credit/margin critique into targets even while maintaining growth assumptions.
关键指标
23 项指标
市值
$432.88B
市盈率 (TTM)
23.6
远期市盈率
13.7
营收增速
20.6%
净资产收益率
53.4%
Beta 系数
1.73
完整指标集
另外 17 项指标
估值结构
估值倍数与现金流框架。
市销率
6.4
市净率
11.5
企业价值 / EBITDA
19.1
质量与资产负债表
利润率、杠杆与流动性。
毛利率
65.8%
营业利润率
36.2%
资产负债率
388.9
流动比率
1.12x
速动比率
1.01x
仓位与价格区间
空头仓位与52周区间位置。
流通盘空头占比
2.6%
空头回补天数
1.77x
52周最高
$329.50
52周最低
$114.50
距52周高点
-54.4%
距52周低点
31.3%
公司分类
板块与行业背景。
板块
Technology
行业
Software - Infrastructure
其他信号
自由现金流
$-24536750080.00
详细分析
估值
At $150.28, ORCL trades at 23.55x trailing , 13.67x forward , 0.86x , 6.43x , and 19.07x on a $432.9B market cap — optically cheap against revenue growth of 20.6% accelerating to a guided 30-34% next quarter, and the mean $241.41 target implies ~61% upside. But the capital-structure adjustment is the honest lens: enterprise value of $581.6B sits 1.34x above market cap on $135.5B of net debt (-31.3% of market cap), the -5.67% FCF yield prices explicit funding risk, and 19.07x is not cheap for a business whose gross margins just declined sequentially per BMO's post-print note. The earnings print strengthened the numerator (RPO $664B, OCI +121%, $30B of new contracts) but the denominator story — margins and cash conversion — is now under active debate, with BMO explicitly flagging the tension of converting backlog without margin deterioration. At 4.97% on the 10-year with the Fed poised to hike, the market will not award full multiples to this balance sheet until the FY27 debt raise prices acceptably and FCF inflects. Net: cheap relative to growth, fairly valued relative to its leverage, with the discount justified until cash generation turns.
资产负债表
The structure remains the vulnerability and the rate cycle is now moving against it: debt/equity of 388.9%, total debt of $167.4B, cash of $31.9B covering only 19% of debt (cash-to-debt and OCF-to-debt both 0.19), net cash of -$135.5B, and trailing FCF of -$24.5B (-5.67% yield) against record quarterly operating cash flow of ~$23B being fully consumed by the AI buildout. Current ratio of 1.12 and quick ratio of 1.01 are adequate for operations but thin against the debt stack, and the ~$40B fiscal-2027 debt plan now faces a 4.97% 10-year with a ~90% probability of a Fed hike next Wednesday — each 25bp of tightening raises the carrying cost on a $167B stack and narrows the refinancing window. No new equity was disclosed this week; the completed $20B ATM remains the executed equity leg of the funding plan. This is still the most levered hyperscaler, and the Fed is now an active adversary rather than a passive backdrop.
增长
Growth is accelerating and contracted years ahead: Q1 revenue grew 30% to $19.3B, total cloud grew 62% to $11.6B, OCI grew 121% to $7.4B, and more than $30B of additional AI cloud contracts were booked in a single quarter, lifting RPO to $664B — roughly 9x annual revenue — while management guided Q2 revenue up 30-34% and cloud revenue up 65-71%. The weak spot is SaaS: cloud applications grew only 10% to $4.2B, a stark contrast that BMO called disappointing and that matters because SaaS carries the high-margin annuity economics that historically funded the model. The growth mix is shifting toward lower-margin, capital-intensive infrastructure delivery — 121% growth is real demand, but each incremental dollar currently arrives with declining gross margin and negative free cash flow. Growth quality, not growth quantity, is the new debate.
生意质量
Gross margin of 65.82%, operating margin of 36.2%, and margin of 45.27% remain elite for the software sector, and the record $23B quarterly operating cash flow confirms the engine runs — but the direction of travel on gross margin is now negative per BMO's sequential read, and of 6.5% is the honest quality measure against an of 53.4% flattered by 388.9% leverage. Short interest is a non-factor at 2.6% of float (short ratio 1.77), insider ownership of 40.5% aligns management, and institutional ownership of 45.8% leaves re-rating capacity. The 121% OCI growth with premium pricing demonstrates Oracle is capturing scarce AI capacity value, but the SaaS deceleration to 10% and the margin tradeoff flagged by BMO mean business quality is temporarily degrading as the mix shifts to debt-funded infrastructure. Quality supports the franchise, not yet the multiple.
资本配置
Capital allocation remains the open question: the completed $20B ATM funded one leg of the buildout at prices roughly half the 52-week high (a permanent per-share cost), the ~$40B FY27 debt raise is still ahead against -$24.5B trailing FCF, and customer prepayments and contracts ($30B added this quarter alone) shift part of the burden to counterparties — the correct sequencing for a leveraged builder, but the equity is bearing the financing risk. The 1.24% dividend yield with a 34.3% payout is safe; buybacks are deprioritized. The decisive watch item is the terms of the next debt tranche at a 4.97% 10-year with a hike imminent — punitive pricing would confirm the bear thesis that equity value is subordinated to the credit market, while acceptable pricing would remove the single largest overhang.
预期修正
Revision momentum remains positive on an annual basis: the +1y estimate has risen from $10.8669 ninety days ago to $11.0212 today and the 0y estimate from $8.04 to $8.13, with zero downward revisions across all four horizons in the last 30 days and one upward revision in the last 7 days at each horizon. The nuance: the 0q and +1q estimates ticked slightly lower over the past week (1.889-to-1.874 and 2.065-to-2.030) — likely post-print rebasing toward the actual $1.92 result and conservative near-term resets — while annual models rose, consistent with analysts accepting the growth story but marking down near-term margin assumptions. The recommendation mix (8 Strong Buy, 28 Buy, 7 Hold, 1 Sell) is unchanged, but post-print price-target actions split: UBS raised $245-to-$250 while BMO cut $220-to-$195, RBC cut $190-to-$165 (to Sector Perform), and Stifel cut $220-to-$200 — revisions are net positive on estimates but net cautious on valuation, exactly the signature of a margin-and-funding debate rather than a demand debate.